EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk factor analysis and optimal cutoff value selection of PSAD for diagnosing clinically significant prostate cancer in patients with negative mpMRI: results from a high-volume center in Southeast China

Shen Lin, Wubin Jiang, Jiafeng Ding, Sida Hao, Hong Chen, Liping Xie, Xiangyi Zheng

World Journal of Surgical Oncology · 2024

DOI: 10.1186/s12957-024-03420-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Surgical Oncology, 2024. Verfasst von Shen Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostate-Specific Antigen, Multiparametric Magnetic Resonance Imaging. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D Program of Zhejiang, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multi-parametric magnetic resonance imaging (mpMRI) is a diagnostic tool used for screening, localizing, and staging prostate cancer. Patients with Prostate Imaging Reporting and Data System (PI-RADS) score of 1 and 2 are considered negative mpMRI, with a lower likelihood of detecting clinically significant prostate cancer (csPCa). However, relying solely on mpMRI is insufficient to completely exclude csPCa, necessitating further stratification of csPCa patients using biomarkers.

Methods

A retrospective study was conducted on mpMRI-negative patients who underwent prostate biopsy at the First Affiliated Hospital of Zhejiang University from January 2022 to June 2023. A total of 607 patients were included based on inclusion and exclusion criteria. Univariate and multivariate logistic regression analysis were performed to identify risk factors for diagnosing csPCa in patients with negative mpMRI. Receiver Operating Characteristic (ROC) curves were plotted to compare the discriminatory ability of different Prostate-Specific Antigen Density (PSAD) cutoff values for csPCa.

Results

Among the 607 patients with negative mpMRI, 73 patients were diagnosed with csPCa. In univariate logistic regression analysis, age, PSA, f/tPSA, prostate volume, and PSAD were all associated with diagnosing csPCa in patients with negative mpMRI ( P < 0.05), with PSAD being the most accurate predictor. In multivariate logistic regression analysis, f/tPSA, age, and PSAD were independent predictors of csPCa ( P < 0.05). PSAD cutoff value of 0.20 ng/ml/ml has better discriminatory ability for predicting csPCa and is a significant risk factor for csPCa in multivariate analysis.

Conclusion

Age, f/tPSA, and PSAD are independent predictors of diagnosing csPCa in patients with negative mpMRI. It is suggested that patients with negative mpMRI and PSAD less than 0.20 ng/ml/ml could avoid prostate biopsy, as a PSAD cutoff value of 0.20 ng/ml/ml has better diagnostic performance than the traditional cutoff value of 0.15 ng/ml/ml.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstate-Specific AntigenMultiparametric Magnetic Resonance ImagingHumansMaleRetrospective StudiesAgedMiddle AgedChinaRisk FactorsPrognosisFollow-Up StudiesHospitals, High-VolumeROC Curve

Stichwörter der Autor:innen

Negative mpMRIPSADProstate biopsyProstate cancerRisk factors

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China.
  • Department of Urology, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China.
  • Department of Urology, Lishui Hospital of Zhejiang University, No. 289 Kuocang Road, Lishui, Zhejiang, 323000, China.
  • Department of Urology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China. xielp@zju.edu.cn.
  • Department of Urology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China. zheng_xy@zju.edu.cn.

Förderung

  • Key R&D Program of Zhejiang
  • National Natural Science Foundation of China

Zitieren

APA

Lin, S., Jiang, W., Ding, J., Hao, S., Chen, H., Xie, L., & Zheng, X. (2024). Risk factor analysis and optimal cutoff value selection of PSAD for diagnosing clinically significant prostate cancer in patients with negative mpMRI: results from a high-volume center in Southeast China. World Journal of Surgical Oncology. https://doi.org/10.1186/s12957-024-03420-7

Vancouver

Lin S, Jiang W, Ding J, Hao S, Chen H, Xie L, et al. Risk factor analysis and optimal cutoff value selection of PSAD for diagnosing clinically significant prostate cancer in patients with negative mpMRI: results from a high-volume center in Southeast China. World Journal of Surgical Oncology. 2024. doi:10.1186/s12957-024-03420-7

BibTeX
@article{Lin2024,
  author = {Lin, Shen and Jiang, Wubin and Ding, Jiafeng and Hao, Sida and Chen, Hong and Xie, Liping and Zheng, Xiangyi},
  title = {Risk factor analysis and optimal cutoff value selection of PSAD for diagnosing clinically significant prostate cancer in patients with negative mpMRI: results from a high-volume center in Southeast China},
  journal = {World Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1186/s12957-024-03420-7}
}
Kostenlos starten →